Work

Reply to: Epidermal Growth Factor Receptor Amplification: Passenger or Partner? Rethinking Biomarkers in Postosimertinib Strategy

Year: 2025

Type: letter

Source: JCO Precision Oncology

DOI: 10.1200/po-25-00827

Author: Jonathan W. Riess

Institution: UC Davis Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415252396

Cites: 10

Cited by:

Related to: 10